• Profile
Close

Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia of Sjogren's syndrome: A double blind control trial

British Journal of Dermatology Feb 22, 2018

Cifuentes M, et al. - The effectiveness of pilocarpine and artificial saliva was evaluated and compared as symptomatic treatments for xerostomia and xerophthalmia in cases with Sjogren's Syndrome (SS). For enhancing salivary and lachrymal secretion in patients with SS, pilocarpine was noted to be more efficacious than artificial saliva. It was the first trial that compared the effectiveness of pilocarpine and artificial saliva as treatments for xerostomia and xerophthalmia in SS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay